Matteo De Pastena

Dr. Matteo De Pastena

General and Pancreatic Surgery, Pancreas Institute, Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Surgery
Verified
Journal Article
Closed access
MPMatteo De Pastena
Matteo De Pastena
SPSalvatore Paiella
Salvatore Paiella
GMGiovanni Marchegiani
Giovanni Marchegiani
GMGiuseppe Malleo
Giuseppe Malleo
DCDebora Ciprani
Debora Ciprani
CBClaudio Bassi
Claudio Bassi

26 June 2018 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
MPMatteo De Pastena
Matteo De Pastena
GMGiovanni Marchegiani
Giovanni Marchegiani
SPSalvatore Paiella
Salvatore Paiella
GMGiuseppe Malleo
Giuseppe Malleo
DCDebora Ciprani
Debora Ciprani
CBClaudio Bassi
Claudio Bassi

2 April 2020 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
MPMatteo De Pastena
Matteo De Pastena
AEAlessandro Esposito
Alessandro Esposito
SPSalvatore Paiella
Salvatore Paiella
NSNiccolò Surci
Niccolò Surci
GMGreta Montagnini
Greta Montagnini
RSRoberto Salvia
Roberto Salvia

7 December 2023 in Pancreatology
Verified
Journal Article
Closed access
EOEizaburo Ohno
Eizaburo Ohno
ABAlberto Balduzzi
Alberto Balduzzi
Susumu HijiokaSusumu Hijioka
Susumu Hijioka
MPMatteo De Pastena
Matteo De Pastena
GMGiovanni Marchegiani
Giovanni Marchegiani
RSRoberto Salvia
Roberto Salvia

1 September 2019 in Surgery
Verified
Journal Article
Closed access
APAlessandra Pulvirenti
Alessandra Pulvirenti
LLLuca Landoni
Luca Landoni
ABAlex Borin
Alex Borin
MPMatteo De Pastena
Matteo De Pastena
MFMartina Fontana
Martina Fontana
CBClaudio Bassi
Claudio Bassi

2 November 2022 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
TRTess M E van Ramshorst
Tess M E van Ramshorst
AGAlessandro Giani
Alessandro Giani
MMMichele Mazzola
Michele Mazzola
SDSafi Dokmak
Safi Dokmak
FFFadhel Samir Ftériche
Fadhel Samir Ftériche
FSfor the European Consortium on Minimally Invasive Pancreatic Surgery
for the European Consortium on Minimally Invasive Pancreatic Surgery
Background: Benchmarking is an important tool for quality comparison and improvement. However, no benchmark values are available for minimally invasive spleen-preserving distal pancreatectomy, either laparoscopically or robotically assisted. The aim of this study was to establish benchmarks for these techniques using two different methods. Methods: Data from patients undergoing laparoscopically or robotically assisted spleen-preserving distal pancreatectomy were extracted from a multicentre database (2006–2019). Benchmarks for 10 outcomes were calculated using the Achievable Benchmark of Care (ABC) and best-patient-in-best-centre methods. Results: Overall, 951 laparoscopically assisted (77.3 per cent) and 279 robotically assisted (22.7 per cent) procedures were included. Using the ABC method, the benchmarks for laparoscopically assisted and robotically assisted spleen-preserving distal pancreatectomy respectively were: 150 and 207 min for duration of operation, 55 and 100 ml for blood loss, 3.5 and 1.7 per cent for conversion, 0 and 1.7 per cent for failure to preserve the spleen, 27.3 and 34.0 per cent for overall morbidity, 5.1 and 3.3 per cent for major morbidity, 3.6 and 7.1 per cent for pancreatic fistula grade B/C, 5 and 6 days for duration of hospital stay, 2.9 and 5.4 per cent for readmissions, and 0 and 0 per cent for 90-day mortality. Best-patient-in-best-centre methodology revealed milder benchmark cut-offs for laparoscopically and robotically assisted procedures, with operating times of 254 and 262.5 min, blood loss of 150 and 195 ml, conversion rates of 5.8 and 8.2 per cent, rates of failure to salvage spleen of 29.9 and 27.3 per cent, overall morbidity rates of 62.7 and 55.7 per cent, major morbidity rates of 20.4 and 14 per cent, POPF B/C rates of 23.8 and 24.2 per cent, duration of hospital stay of 8 and 8 days, readmission rates of 20 and 15.1 per cent, and 90-day mortality rates of 0 and 0 per cent respectively. Conclusion: Two benchmark methods for minimally invasive distal pancreatectomy produced different values, and should be interpreted and applied differently.